| ASSET | QUARTER | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | Q4 2014 | 125% |
Axon Enterprise (AXON) | Q4 2014 | 72.62% |
QXO (QXO) | Q4 2014 | 69.23% |
Applied Digital (APLD) | Q4 2014 | 65.57% |
Ionis Pharmaceuticals (IONS) | Q4 2014 | 58.31% |
Incyte (INCY) | Q4 2014 | 48.78% |
United Airlines (UAL) | Q4 2014 | 46.62% |
MACOM Technology Solutions (MTSI) | Q4 2014 | 43.75% |
Neurocrine Biosciences (NBIX) | Q4 2014 | 41.93% |
Delta Air Lines (DAL) | Q4 2014 | 39.45% |
DexCom (DXCM) | Q4 2014 | 38.39% |
Genmab A-S (GMAB) | Q4 2014 | 38.21% |
SS&C Technologies (SSNC) | Q4 2014 | 34.21% |
Lululemon Athletica (LULU) | Q4 2014 | 33.41% |
Electronic Arts (EA) | Q4 2014 | 32.3% |
AAON (AAON) | Q4 2014 | 31.96% |
Lowe's Companies (LOW) | Q4 2014 | 30.98% |
Heico (HEI) | Q4 2014 | 30.96% |
Fair Isaac (FICO) | Q4 2014 | 30.75% |
Tower Semiconductor (TSEM) | Q4 2014 | 30.3% |
Ryanair Holdings PLC ADR (RYAAY) | Q4 2014 | 29.09% |
Tractor Supply (TSCO) | Q4 2014 | 28.65% |
Southwest Airlines (LUV) | Q4 2014 | 28.54% |
Vicor (VICR) | Q4 2014 | 28.45% |
O’Reilly Automotive (ORLY) | Q4 2014 | 28.44% |
Large-cap stocks are treated as having a market cap of $10B+.